IL-27 EXPRESSED IN THE TUMOR MICROENVIRONMENT IS CORRELATED WITH PD-L1 LEVELS AND CAN INDUCE PD-L1 EXPRESSION ON IMMUNE AND TUMOR CELLS

被引：0
|
作者：
Golan, Karin [1 ]
Masia, Ricard [1 ]
Yang, Yu [1 ]
Ren, Yue [1 ]
White, Kerry [1 ]
Lee, Benjamin [1 ]
Palombella, Vito [1 ]
Hill, Jonathan [1 ]
机构：
[1] Surface Oncol, Cambridge, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1082
引用
收藏
页码：A1124 / A1124
页数：1
相关论文
共 50 条
  • [41] PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
    Tang, Haidong
    Liang, Yong
    Anders, Robert A.
    Taube, Janis M.
    Qiu, Xiangyan
    Mulgaonkar, Aditi
    Liu, Xin
    Harrington, Susan M.
    Guo, Jingya
    Xin, Yangchun
    Xiong, Yahong
    Nham, Kien
    Silvers, William
    Hao, Guiyang
    Sun, Xiankai
    Chen, Mingyi
    Hannan, Raquibul
    Qiao, Jian
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 580 - 588
  • [42] Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade
    Maekawa, Naoya
    Konnai, Satoru
    Ikebuchi, Ryoyo
    Okagawa, Tomohiro
    Adachi, Mami
    Takagi, Satoshi
    Kagawa, Yumiko
    Nakajima, Chie
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    PLOS ONE, 2014, 9 (06):
  • [43] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Tang, Fei
    Zheng, Pan
    CELL AND BIOSCIENCE, 2018, 8
  • [44] Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
    Fei Tang
    Pan Zheng
    Cell & Bioscience, 8
  • [45] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Qian, Jiawen
    Wang, Chen
    Wang, Bo
    Yang, Jiao
    Wang, Yuedi
    Luo, Feifei
    Xu, Junying
    Zhao, Chujun
    Liu, Ronghua
    Chu, Yiwei
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [46] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Jiawen Qian
    Chen Wang
    Bo Wang
    Jiao Yang
    Yuedi Wang
    Feifei Luo
    Junying Xu
    Chujun Zhao
    Ronghua Liu
    Yiwei Chu
    Journal of Neuroinflammation, 15
  • [47] PD-L1 immune suppression in cancer: Tumor cells or host cells?
    Kleinovink, Jan Willem
    van Hall, Thorbald
    Ossendorp, Ferry
    Fransen, Marieke F.
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [48] Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
    Tu, Jingyao
    Xu, Haoran
    Ma, Li
    Li, Chunya
    Qin, Wan
    Chen, Xinyi
    Yi, Ming
    Sun, Li
    Liu, Bo
    Yuan, Xianglin
    THERANOSTICS, 2022, 12 (02): : 747 - 766
  • [49] Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test
    Keyu Yuan
    Jiangping Wu
    Yanjie Zhao
    Shuzhen Lyu
    Quan Zhou
    Feng Shi
    Yanping Li
    Qingkun Song
    Diagnostic Pathology, 17
  • [50] Beyond PD-L1: Unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumor microenvironment
    Gumuzio, Juan
    Calleja, Veronique
    Miles, James
    Sancehz-Magraner, Lissete
    Aguirre, Fernando
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345